EVAX

2.25010.84%
JS

Jeffrey S. Weber

Member of Advisory Board

Dr. Jeffrey S. Weber, M.D., Ph.D., also known as Jeff, was Member of Scientific Advisory Board of OncoC4, Inc. until July 2025. Dr. Weber served as Member of the Scientific Advisory Board at Turnstone Biologics Corp. since November 2023 until August 2024. He is Chief Scientific Advisor at NexImmune, Inc. and also serves as its Co-Chairman of Scientific Advisory Board since May 2022 and served as its Chairman of Scientific Advisory Board since May 2021 until May 2022 and has been its Member of Autoimmune and Infectious Diseases Scientific Advisory Board since January 2022. Dr. Weber serves as a Member of Clinical Advisory Board at ImCheck Therapeutics SAS. Dr. Weber serves as Deputy Director of Perlmutter, Co-Director of Melanoma Program at the New York University (NYU)-Langone Cancer Center and Head of Experimental Therapeutics at NYU Langone Health System (formerly known as NYU Langone Medical Center LLC). Dr. Weber is a Member of Advisory Board at Evaxion A/S (formerly known as Evaxion Biotech A/S). Dr. Weber serves as Member of the Advisory Board at Protean BioDiagnostics Inc. He was Head of the Melanoma Center of Excellence at H. Lee Moffitt Cancer Center and Professor in the Department of Oncologic Sciences. He had been the Chairman of Scientific Advisory Board at SELLAS Life Sciences Group, Inc. since June 1, 2018 until 2025. Dr. Weber serves as a Member of Scientific Advisory Board at cCAM Biotherapeutics Ltd. He serves as a Member of Scientific Advisory Board at ImmuRx, Inc. Dr. Weber serves as a Member of Scientific Advisory Board of Immunotope, Inc. He has been Member of Scientific Advisory Board of Ichor Medical Systems, Inc. since joining in 2002. He served as a Member of Scientific Advisory Board for Melanoma. Dr. Weber served as the Scientific Advisor of Alligator Bioscience AB. Dr. Weber serves as an Associate Professor and Associate Director for Clinical Research at University of Southern California/Norris Comprehensive Cancer Center. Dr. Weber is a Senior Member and Director of the Donald A Adam Comprehensive Melanoma Research Center at Moffitt Cancer Center in Tampa, Florida. Dr. Weber is a Medical Oncologist and Translational Clinical Trialist with an interest in melanoma immunotherapy and its intersection with targeted therapy. Dr. Weber has been NIH funded to perform clinical trials in melanoma, has held 12 investigator INDs with the FDA and has over 120 citations on his CV. Dr. Weber is an Associate Editor at Journal of the National Cancer Institute and Clinical Cancer Research, has served on numerous study sections. Dr. Weber served as a Member of Scientific Advisory Board of Celyad Oncology SA (formerly Celyad SA) since April 6, 2016. Dr. Weber has been Member of Scientific Advisory Board at SELLAS Life Sciences Group, Inc. since November 17, 2016. Dr. Weber served as a Member of Scientific Advisory Board for Celldex Therapeutics Inc. Dr. Weber serves as a Professor of Oncology and Medicine at H. Lee Moffitt Cancer Center in Tampa, Florida. He worked as a Senior Investigator in the Surgery Branch of the National Cancer Institute at the National Institutes of Health. He served as an Assistant Professor of Medicine at the University of California, Irvine. In 1995, he joined the University of Southern California. Dr. Weber served as Chief of Medicine at the USC's Norris Cancer Hospital in Los Angeles, California and Chief of Medical Oncology at the USC's Keck School of Medicine. Dr. Weber serves in many study sections for NCI and is a Member of the Editorial Boards of Clinical Cancer Research, Human Gene Therapy and Journal of Immunotherapy. Dr. Weber serves as Deputy Director at the Laura and Isaac Perlmutter Cancer Center at the NYU Langone Medical Center. He is the holder of the Bearle and Lucy Adams Chair in Cancer Research, Director of the USC/Norris Melanoma Center and Co-Director of the USC/Norris Developmental Therapeutics Program. He is a reviewer for Blood, Cancer, Cancer Gene Therapy, Cancer Research, Journal of Clinical Investigation, Journal of Clinical Oncology, Journal of Immunology and New England Journal of Medicine. Dr. Weber is an author of numerous scientific publications in peer-reviewed journals and a Principal Investigator of NCI grants on several ongoing studies funded by the National Cancer Institute (NCI) as well as industry, including trials in clinical drug development, vaccines and studies on autoimmunity and melanoma. Dr. Weber sat on the NCI's Clinical Oncology Study section as well as the boards of the Melanoma Research Foundation and the Melanoma Therapeutics Foundation He served as a Chair of the Veterans Administration's clinical oncology study section. Dr. Weber has published more than 150 articles in the top peer-reviewed journals in his field including New England Journal of Medicine and Nature Medicine. Dr. Weber had been Consulting Medical Director at Altor BioScience Corporation since January 2007. Dr. Weber served as a Member of Scientific Advisory Board at Iovance Biotherapeutics, Inc. (formerly known as Lion Biotechnologies, Inc.) He served as a Member of Clinical Advisory Board of Targa Therapeutics Corp. and Altor BioScience Corporation. Dr. Weber was the recipient of the Bob Chandler Courage Award from the University of Southern California in 1998, the K24 Mid-Career Mentor Award from NIH from 2000 to 2004 and the Best Doctors in America Award from 2004 to 2007. Dr. Weber was also the first investigator who demonstrated that PD-1 blocking antibodies had encouraging activity in resected melanoma patients. Coming to Moffitt in 2007, He is Board Certified in Internal Medicine and Medical Oncology. He is a specialist in cancer immunotherapy. Dr. Weber earned his Medical Degree from New York University Medical School in 1980. He earned a Ph.D. in Molecular Cell Biology from Rockefeller University in New York 1979. Dr. Weber did an Internship and Residency at the University of California at San Diego. Dr. Weber was Member of Scientific Advisory Board of Biond Biologics Ltd until February 2026.

Positions